Antibiotics right away or later for lung infections from a breathing machine
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study looks at when to start antibiotics for a lung infection you may have gotten while on a breathing machine. It compares starting them right away versus waiting for the test results to be sure you need them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been on a breathing machine for more than 2 days.
- You have a suspected first-time lung infection (pneumonia) from the ventilator.
- A fluid sample from your lungs has been taken within the last 2 hours for testing.
- You are 18 years or older.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a rapid test to find the exact bacteria causing your pneumonia can help doctors choose the right antibiotics faster, which might improve your recovery. The study compares this approach to usual care in patients on ventilators.
This trial tests whether giving preventive antibiotics to adults on breathing machines lowers the risk of developing pneumonia during ventilation. It is a double-blind study, meaning neither you nor your doctor will know if you receive the antibiotic or a placebo.
This study tests a new way to quickly diagnose pneumonia in children on breathing machines in the ICU. It uses information from the body and germs to find the right treatment faster.
This study tests whether giving antibiotics in a personalized way, based on how your body processes them, works better than the standard dose for treating lung infections in the ICU. If you qualify, you'll be randomly assigned to get either the usual dose or a dose adjusted to your blood levels, with the goal of improving your recovery.
This study looks at different types of lung infections in ICU patients on breathing machines. By analyzing fluid from your lungs, researchers hope to better understand pneumonia and improve treatment.
This trial tests whether a medicine called interferon gamma can improve outcomes in adults with a first episode of pneumonia that develops after being on a ventilator in the ICU. It is designed for specific ICU timing, infection severity, and immune marker levels, and it compares treatment on top of standard care.
Hear when a new Ventilator-Associated Pneumonia (VAP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.